Package 0363-2350-52

Brand: no drip severe anefrin nasal

Generic: 0.05% oxymetazoline hcl
NDC Package

Package Facts

Identity

Package NDC 0363-2350-52
Digits Only 0363235052
Product NDC 0363-2350
Description

1 BOTTLE, SPRAY in 1 CARTON (0363-2350-52) / 15 mL in 1 BOTTLE, SPRAY

Marketing

Marketing Status
Marketed Since 2024-03-31
Brand no drip severe anefrin nasal
Generic 0.05% oxymetazoline hcl
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["NASAL"], "spl_id": "3091b846-549f-496e-8878-404309f6baeb", "openfda": {"unii": ["K89MJ0S5VY"], "rxcui": ["1000990"], "spl_set_id": ["c126e969-56f3-47b4-a011-02ff150eccb8"], "manufacturer_name": ["Walgreens Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, SPRAY in 1 CARTON (0363-2350-52)  / 15 mL in 1 BOTTLE, SPRAY", "package_ndc": "0363-2350-52", "marketing_start_date": "20240331"}], "brand_name": "No Drip Severe Anefrin Nasal", "product_id": "0363-2350_3091b846-549f-496e-8878-404309f6baeb", "dosage_form": "SPRAY", "pharm_class": ["Imidazolines [CS]", "Increased Sympathetic Activity [PE]", "Vasoconstriction [PE]", "Vasoconstrictor [EPC]"], "product_ndc": "0363-2350", "generic_name": "0.05% Oxymetazoline HCL", "labeler_name": "Walgreens Company", "product_type": "HUMAN OTC DRUG", "brand_name_base": "No Drip Severe Anefrin Nasal", "active_ingredients": [{"name": "OXYMETAZOLINE HYDROCHLORIDE", "strength": "50 mg/100mL"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20240331", "listing_expiration_date": "20261231"}